Market LIVE
Published markets; coverage varies by country
Product profile · United States

BALVERSA

 ·  Patent Litigation & Settlement History ↓

IngredientERDAFITINIB
Application typeNDA
Application212018
Product003
Dosage formTABLET
RouteORAL
Strength5MG
Approval date2019-04-12
Marketing statusPrescription
Status event—
ApplicantJANSSEN BIOTECH
Product source

Current GenericRadar decision

Year2033
SelectionDEEP_REVIEW
ReviewFINAL
Anchor typePATENT
Anchor date2033-04-12
Patent anchor2033-04-12
Exclusivity anchor2027-01-19
Protection date2038-02-02
First Final ANDA—
Status event—

POST_ANCHOR_RIGHTS_EXIST; US:NDA:212018:003; exact Final ANDA not verified; not proof of generic absence

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
94640712031-04-28U U-3805NYU
English description not available.
———
94640712031-04-28ORANGE_BOOK U-3805NYU
English description not available.
———
88956012033-04-12DS/DP —YNTRUE_DS
English description not available.
———
88956012033-04-12ORANGE_BOOK —YNTRUE_DS
English description not available.
———
99027142035-03-26DP —NNOTHER
English description not available.
———
99027142035-03-26ORANGE_BOOK —NNOTHER
English description not available.
———
120376442035-10-18U U-3972NNU
English description not available.
———
120376442035-10-18ORANGE_BOOK U-3972NNU
English description not available.
———
108984822036-02-09DP/U U-3066NNDP
English description not available.
———
108984822036-02-09DP/U U-3067NNDP
English description not available.
———
108984822036-02-09DP/U U-3805NNDP
English description not available.
———
108984822036-02-09DP/U U-3065NNDP
English description not available.
———
108984822036-02-09DP/U U-3806NNDP
English description not available.
———
108984822036-02-09DP/U U-3807NNDP
English description not available.
———
108984822036-02-09DP/U U-2518NNDP
English description not available.
———
108984822036-02-09ORANGE_BOOK U-2518,U-3065,U-3066,U-3067,U-3805,U-3806,U-3807NNDP
English description not available.
———
116846202036-02-09U U-3807NNU
English description not available.
———
116846202036-02-09U U-3806NNU
English description not available.
———
116846202036-02-09U U-3805NNU
English description not available.
———
116846202036-02-09ORANGE_BOOK U-3805,U-3806,U-3807NNU
English description not available.
———
126784982036-06-13U U-4584NNU
English description not available.
———
126784982036-06-13ORANGE_BOOK U-4584NNU
English description not available.
———
104784942036-08-13U U-3902NNU
English description not available.
———
104784942036-08-13ORANGE_BOOK U-3902NNU
English description not available.
———
110771062038-02-02U U-3808NNU
English description not available.
———
110771062038-02-02U U-3196NNU
English description not available.
———
110771062038-02-02ORANGE_BOOK U-3196,U-3808NNU
English description not available.
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
NCE2019-04-122024-04-12English description not available.YY2024-04-12
I-930
Full coverage date: 2024-04-12
Source
I-9302024-01-192027-01-19English description not available.YY2027-01-19—Source
I-9302024-01-192027-01-19English description not available.YY2027-01-19
I-930
Full coverage date: 2027-01-19
Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (12)
TypeDateRoleBasisSource
PATENT2031-04-28HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2033-04-12CANONICAL_ANCHOREnglish description not available.Source
PATENT2035-03-26FTO_TAILEnglish description not available.Source
PATENT2035-10-18FTO_TAILEnglish description not available.Source
PATENT2036-02-09FTO_TAILEnglish description not available.Source
PATENT2036-02-09FTO_TAILEnglish description not available.Source
PATENT2036-06-13FTO_TAILEnglish description not available.Source
PATENT2036-08-13FTO_TAILEnglish description not available.Source
PATENT2038-02-02FTO_TAILEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_STATUS2033-04-12CANONICAL_DECISIONPOST_ANCHOR_RIGHTS_EXIST; US:NDA:212018:003; exact Final ANDA not verified; not proof of generic absenceSource
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.